Pro-Dex Inc (PDEX)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $210.11M
Last updated: Nov 17, 2026 at 4:15 PM ET
Pro-Dex Inc (PDEX) Statistics
Pro-Dex (PDEX) has a market cap of $210.11M and an enterprise value of $219.39M. Its return on invested capital of 18.98% compares with a 3.12% median across 6 similar companies.
Total Valuation
Enterprise value is 4.42% above the market cap, as debt exceeds cash.
| Market Cap | $210.11M |
|---|---|
| Enterprise Value | $219.39M |
| Latest price (Nov 17, 2026) | $61.93 |
Key Dates
The next earnings report is expected on Jan 27, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Jan 27, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Fiscal Year End | June |
Valuation Ratios
Sales and book value multiples are 2.6x and 4.2x. Its year-end P/E ranged from 4.8x to 23.4x from 2016 to 2025.
| P/E Ratio | 17.0x |
|---|---|
| Forward P/E | 19.6x |
| P/S Ratio | 2.6x |
| Forward P/S | 2.5x |
| P/B Ratio | 4.2x |
| P/TBV Ratio | 4.9x |
| P/FCF Ratio | 29.6x |
| P/OCF Ratio | 29.0x |
Enterprise Valuation
Counting debt and cash, the company is valued at 11.8x EBITDA and 30.9x free cash flow.
| EV / Earnings | 16.1x |
|---|---|
| EV / Sales | 2.8x |
| EV / EBITDA | 11.8x |
| EV / FCF | 30.9x |
Price Statistics
The stock is up 92.99% over 52 weeks and trades 4.38% below its 50-day average.
| Beta (1Y) | 1.25 |
|---|---|
| 52-Week Change | +92.99% |
| 1-Month Change | +7.33% |
| 3-Month Change | -7.48% |
| 6-Month Change | +1.89% |
| 5-Year Change | +139.64% |
| 10-Year Change | +1150.75% |
| Total Return (1Y) | +92.99% |
| Total Return (3Y CAGR) | +53.55% |
| Total Return (5Y CAGR) | +24.73% |
| Return vs SPY (1Y) | +92.56% |
| Max Drawdown (1Y) | -21.47% |
| Max Drawdown (3Y) | -65.36% |
| Sharpe Ratio (1Y) | 1.30 |
| Correlation with SPY (1Y) | 0.31 |
| 50-Day Average | $64.77 |
| 200-Day Average | $58.01 |
| 52-Week Range | $28.81 to $77.00 |
| RSI (14 Days) | 45.9 |
| Average Volume (20 Days) | 38.42K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 4.10x current liabilities, and total debt is 0.37x shareholder equity.
| Current Ratio | 4.10x |
|---|---|
| Quick Ratio | 2.45x |
| Debt / Equity | 0.37x |
| Debt / EBITDA | 0.99x |
| Debt / FCF | 2.58x |
| Interest Coverage | 20.06x |
Returns and Efficiency
Return on invested capital is 18.98% over the last 12 months, against a 5-year average of 13.00%.
| Return on Equity (ROE) | 28.68% |
|---|---|
| Return on Assets (ROA) | 18.34% |
| Return on Invested Capital (ROIC) | 18.98% |
| ROE (5Y Average) | 20.09% |
| ROA (5Y Average) | 12.01% |
| ROIC (5Y Average) | 13.00% |
| Asset Turnover | 1.14x |
| Inventory Turnover | 2.43x |
| Receivables Turnover | 3.81x |
| Cash Conversion Cycle | 213 days |
Taxes
Income tax took 24.16% of pretax income over the last 12 months.
| Income Tax (TTM) | $4.35M |
|---|---|
| Effective Tax Rate | 24.16% |
Scores
PDEX has an Altman Z-Score of 7.77, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 7.77 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $77.55M over the last 12 months is up 16.45% from the 12 months before.
| Revenue | $77.55M |
|---|---|
| Revenue Growth (YoY) | +16.45% |
| Gross Profit | $24.34M |
| Operating Income | $12.99M |
| Pretax Income | $18.02M |
| Net Income | $13.66M |
| Reported EPS (TTM) | $3.65 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 63.92% of the $74.51M in total assets.
| Cash and Equivalents | $8.19M |
|---|---|
| Total Debt | $17.47M |
| Net Debt | $9.28M |
| Net Debt Per Share | $2.88 |
| Working Capital | $40.27M |
| Shareholder Equity | $47.63M |
| Book Value Per Share | $14.77 |
| Tangible Book Value | $40.42M |
| Tangible Book Per Share | $12.53 |
| Total Assets | $74.51M |
| Total Liabilities | $26.88M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $483.00K of capital spending, operating cash flow left $6.76M of free cash flow.
| Operating Cash Flow | $7.24M |
|---|---|
| Capital Expenditures | $483.00K |
| Free Cash Flow | $6.76M |
| FCF Per Share | $2.11 |
| Depreciation and Amortization | $1.48M |
| Share Repurchases | $3.41M |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is 16.75%, against a 5-year average of 14.16%.
| Gross Margin | 31.38% |
|---|---|
| Operating Margin | 16.75% |
| Pretax Margin | 23.23% |
| Net Margin | 17.62% |
| FCF Margin | 8.72% |
| Gross Margin (5Y Average) | 29.32% |
| Operating Margin (5Y Average) | 14.16% |
| Net Margin (5Y Average) | 12.25% |
Growth
Revenue grew 18.94% a year over 3 years, and EPS 46.65% a year.
| Revenue Growth (3Y CAGR) | +18.94% |
|---|---|
| Revenue Growth (5Y CAGR) | +15.32% |
| EPS Growth (3Y CAGR) | +46.65% |
| EPS Growth (5Y CAGR) | +29.83% |
| FCF Growth (3Y CAGR) | +14.62% |
| Operating Income Growth (3Y CAGR) | +31.13% |
| Book Value Per Share Growth (2Y CAGR) | +10.77% |
| Tangible Book Per Share Growth (2Y CAGR) | +10.88% |
Dividends and Yields
PDEX does not pay a dividend. Its free cash flow yield is 3.38%.
| Earnings Yield | 5.88% |
|---|---|
| FCF Yield | 3.38% |
| Buyback Yield | 1.66% |
| Shareholder Yield | 1.66% |
Stock Splits
The last split was a 1-for-3 reverse split on Jun 18, 2010.
| Last Split Date | Jun 18, 2010 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:3 |
Peer Position
Against 3 similar companies, PDEX has the 3rd highest P/E.
P/E RatioPeer median 21.6x
P/S RatioPeer median 2.6x
ROICPeer median 3.12%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +6.52%
| P/E Ratio | 17.0x vs 21.6x median |
|---|---|
| P/S Ratio | 2.6x vs 2.6x median |
| ROIC | 18.98% vs 3.12% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +16.45% vs +6.52% median |
Analyst Forecast
Consensus estimates put revenue growth at 5.80% and EPS growth at -9.82% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +5.80% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -9.82% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PDEX
What is PDEX's market cap?
Pro-Dex has a market cap of $210.11M. Its enterprise value, which adds debt and subtracts cash, is $219.39M.
What is PDEX's P/E ratio?
Pro-Dex has a trailing P/E ratio of 17.0x and a forward P/E of 19.6x.
How many shares of PDEX are outstanding?
Pro-Dex has 3.23M shares outstanding. The count is down 1.83% from a year earlier.
Does PDEX pay a dividend?
No. Pro-Dex does not pay a dividend.
How much debt does PDEX have?
Pro-Dex has $17.47M of total debt and $8.19M of cash and equivalents, a net debt position of $9.28M.
PDEX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors